이상반응 보고

VAERS ID	1398515
성별	여성
나이	62세
주 코드
제약회사	MODERNA
로트 번호
예방접종 횟수	2
접종일	2021-06-03
발병일	2021-06-04
상태	회복

증상

• 다한증(Hyperhidrosis)
• 감각이상(Paraesthesia)
• 오한(Chills)
• 졸도(Syncope)

이환 중 질병

지병

기타 의료

이전 예방접종

알레르기

임상 검사

증상 상세

moderate to severe fainting spell; tingling in legs and hands; profuse sweating; chills; This spontaneous case was reported by a consumer and describes the occurrence of SYNCOPE (moderate to severe fainting spell) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.
The occurrence of additional non-serious events is detailed below.
No Medical History information was reported.
On 03-Jun-2021 at 2:10 PM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form.
On 04-Jun-2021, the patient experienced PARAESTHESIA (tingling in legs and hands), HYPERHIDROSIS (profuse sweating) and CHILLS (chills).
On 04-Jun-2021 at 12:15 PM, the patient experienced SYNCOPE (moderate to severe fainting spell) (seriousness criterion medically significant).
On 04-Jun-2021, SYNCOPE (moderate to severe fainting spell), HYPERHIDROSIS (profuse sweating) and CHILLS (chills) had resolved.
At the time of the report, PARAESTHESIA (tingling in legs and hands) outcome was unknown.
It was reported the patient did not go to ER but did consider calling an ambulance if the initial part of the spell did not pass within another 30 minutes.
No treatment and concomitant medication information reported.
Company Comment : Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.